HK1037619A1 - Indole derivatives. - Google Patents

Indole derivatives.

Info

Publication number
HK1037619A1
HK1037619A1 HK01108363A HK01108363A HK1037619A1 HK 1037619 A1 HK1037619 A1 HK 1037619A1 HK 01108363 A HK01108363 A HK 01108363A HK 01108363 A HK01108363 A HK 01108363A HK 1037619 A1 HK1037619 A1 HK 1037619A1
Authority
HK
Hong Kong
Prior art keywords
indole derivatives
indole
derivatives
Prior art date
Application number
HK01108363A
Other languages
English (en)
Inventor
Noritsugu Yamasaki
Takafumi Imoto
Teruo Oku
Hiroshi Kayakiri
Osamu Onomura
Takahiro Hiramura
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of HK1037619A1 publication Critical patent/HK1037619A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
HK01108363A 1998-04-06 2001-11-28 Indole derivatives. HK1037619A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9362598 1998-04-06
PCT/JP1999/001798 WO1999051574A1 (fr) 1998-04-06 1999-04-05 Derives d'indole

Publications (1)

Publication Number Publication Date
HK1037619A1 true HK1037619A1 (en) 2002-02-15

Family

ID=14087520

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108363A HK1037619A1 (en) 1998-04-06 2001-11-28 Indole derivatives.

Country Status (8)

Country Link
US (1) US20050171185A1 (xx)
EP (1) EP1070705A4 (xx)
KR (1) KR20010052235A (xx)
CN (1) CN1150167C (xx)
BR (1) BR9909440A (xx)
CA (1) CA2327397A1 (xx)
HK (1) HK1037619A1 (xx)
WO (1) WO1999051574A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000028991A1 (fr) * 1998-11-13 2000-05-25 Fujisawa Pharmaceutical Co., Ltd. Remedes contre le syndrome des ovaires polykystiques
WO2002013798A2 (en) * 2000-08-11 2002-02-21 Pfizer Limited Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
US6638965B2 (en) 2000-11-01 2003-10-28 Boehringer Ingelheim Pharma Kg Substituted indolinones, preparation thereof and their use as pharmaceutical compositions
CA2436576A1 (en) * 2001-02-02 2002-08-08 Pfizer Inc. Treatment of diabetes mellitus using vardenafil
DE60223936D1 (de) * 2001-09-05 2008-01-17 Eisai R&D Man Co Ltd Mittel zur anregung des appetits und mittel zur behandlung von anorexie
US20050197376A1 (en) * 2004-03-02 2005-09-08 Fujisawa Pharmaceutical Co. Ltd. Concomitant drugs
CN112250627B (zh) 2014-10-06 2024-02-02 弗特克斯药品有限公司 囊性纤维化跨膜转导调节因子调节剂
ES2946970T3 (es) 2016-03-31 2023-07-28 Vertex Pharma Regulador de conductancia transmembrana de moduladores de fibrosis quística
EP3519401B1 (en) 2016-09-30 2021-09-29 Vertex Pharmaceuticals Incorporated Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
IL277491B (en) 2016-12-09 2022-08-01 Vertex Pharma Modulatory modulation of transmembrane conductance in cystic fibrosis, pharmaceutical preparations, treatment methods, and a process for creating the modulator
EP3634402A1 (en) 2017-06-08 2020-04-15 Vertex Pharmaceuticals Incorporated Methods of treatment for cystic fibrosis
AU2018304168B2 (en) 2017-07-17 2023-05-04 Vertex Pharmaceuticals Incorporated Methods of treatment for cystic fibrosis
CN111051280B (zh) 2017-08-02 2023-12-22 弗特克斯药品有限公司 制备吡咯烷化合物的方法
US10654829B2 (en) 2017-10-19 2020-05-19 Vertex Pharmaceuticals Incorporated Crystalline forms and compositions of CFTR modulators
MX2020005753A (es) 2017-12-08 2020-08-20 Vertex Pharma Procesos para producir moduladores de regulador de conductancia transmembranal de fibrosis quistica.
TWI810243B (zh) 2018-02-05 2023-08-01 美商維泰克斯製藥公司 用於治療囊腫纖化症之醫藥組合物
EP3774825A1 (en) 2018-04-13 2021-02-17 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
US11681922B2 (en) * 2019-11-26 2023-06-20 Numenta, Inc. Performing inference and training using sparse neural network

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916774D0 (en) * 1989-07-21 1989-09-06 Bayer Ag New indole derivatives,a process for their preparation and their use in medicaments
GB9122590D0 (en) * 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
EP0882718B1 (en) * 1995-12-28 2005-08-31 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives
AU4400597A (en) * 1996-10-08 1998-05-05 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
WO1999000359A1 (fr) * 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Derives de noyau aromatique
CA2295239A1 (en) * 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
TW453999B (en) * 1997-06-27 2001-09-11 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US6046199A (en) * 1998-01-14 2000-04-04 Cell Pathways, Inc. Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives

Also Published As

Publication number Publication date
BR9909440A (pt) 2000-12-26
EP1070705A4 (en) 2002-04-17
CN1150167C (zh) 2004-05-19
WO1999051574A1 (fr) 1999-10-14
US20050171185A1 (en) 2005-08-04
EP1070705A1 (en) 2001-01-24
KR20010052235A (ko) 2001-06-25
CA2327397A1 (en) 1999-10-14
CN1303371A (zh) 2001-07-11

Similar Documents

Publication Publication Date Title
ZA988078B (en) Substituted oxindole derivatives.
ZA99254B (en) Benzosulfone derivatives.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
ZA200007593B (en) Quinoline Derivatives.
MXPA02005101A (es) Derivados de indol canabimimeticos.
HK1051037A1 (en) Benzodiazepine derivatives.
ZA200202544B (en) Benzodiazepine derivatives.
HK1042295A1 (zh) 1h-咪唑並吡啶衍生物
ZA200005237B (en) Biocidal benzylbiphenyl derivatives.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
GB9910384D0 (en) Alpha-ketoamide derivatives
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
HK1037619A1 (en) Indole derivatives.
ZA992191B (en) Piperidine derivatives.
ZA991550B (en) Cyclohexanediole derivatives.
MXPA01012041A (es) Derivados de indol.
GB9825988D0 (en) Indole derivatives
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
EG23802A (en) 2-Phenylpyran-4-one derivatives
HK1040991A1 (zh) 2-雜芳基-3，4-二氫-2h-吡咯衍生物
HK1049161A1 (en) Indole derivatives.
ZA200101830B (en) Piperidine derivatives.
ZA982436B (en) Thiazolimine derivatives.
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080405